Lyell Immunopharma, Inc. Common Stock — Institutional Ownership
Which tracked institutions hold LYEL, and how they changed the position last quarter. Latest holdings as of Jun 30, 2026. Source: SEC 13-F filings.
18
Funds holding
$42939933
Total value held
Buying
12 added/new · 3 reduced
| # | Institution | Value | Shares | Δ Shares | Change (QoQ) |
|---|---|---|---|---|---|
| 1 | Gsk Plc | $21252859 | 1512659 | — | Held |
| 2 | Blackrock, Inc. | $10177005 | 724342 | +532522 | +277.62% |
| 3 | Alphabet Inc. | $4120247 | 293256 | — | Held |
| 4 | State Street Corp | $2603774 | 185322 | +112800 | +155.54% |
| 5 | Northern Trust Corp | $1664925 | 118500 | +88220 | +291.35% |
| 6 | Goldman Sachs Group Inc | $1219245 | 86779 | -27712 | -24.20% |
| 7 | Morgan Stanley | $520553 | 37050 | -19101 | -34.02% |
| 8 | Ubs Group Ag | $365048 | 25982 | +25982 | NEW BUY |
| 9 | Bank Of New York Mellon Corp | $346656 | 24673 | +24673 | NEW BUY |
| 10 | Invesco Ltd. | $195492 | 13914 | +13914 | NEW BUY |
| 11 | Bank Of America Corp /De/ | $152737 | 10871 | -22450 | -67.37% |
| 12 | Wells Fargo & Company/Mn | $112470 | 8005 | +7880 | +6304.00% |
| 13 | Citigroup Inc | $70601 | 5025 | +792 | +18.71% |
| 14 | Barclays Plc | $66246 | 4715 | +3044 | +182.17% |
| 15 | Jpmorgan Chase & Co | $61149 | 4796 | +3328 | +226.70% |
| 16 | Royal Bank Of Canada | $10000 | 742 | +491 | +195.62% |
| 17 | Us Bancorp \De\ | $815 | 58 | — | Held |
| 18 | Amalgamated Financial Corp. | $111 | 21960 | +21960 | NEW BUY |
Aggregated across tracked institutional filers. Reported quarterly on SEC Form 13-F and may lag. For research only — not investment advice.